According to the available evidence, miR-223 suppresses the metastasis of cervical cancer cells, preventing the process of EMT by augmenting E-cadherin and α-cadherin and reducing the mesenchymal marker vimentin. This evidence concerns the gene CDH1 and cervical carcinoma.